TURKU, FINLAND--(Marketwired - Jun 4, 2013) - Biotie Therapies Corp. ("Biotie") today announced that it has obtained an exclusive option to acquire Neurelis, Inc. ("Neurelis"), a private specialty ...

The legal battle over the scope of orphan drug exclusivity continues, as the U.S. Food and Drug Administration (“FDA”) has recently lost a second case concerning the exclusivity provisions of the ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters, in ...

Company's Ambassadors to share their journeys with epilepsy and meaningfully connect with the epilepsy community in first east coast event SAN DIEGO, April 23, 2026 /PRNewswire/ -- Neurelis, Inc., the ...

Presentation highlights study-enrollment challenges and strategies to overcome potential barriers "Data from clinical studies of repetitive seizures in early childhood are critical to help advance new ...

-- Funds to be utilized to complete development work and begin commercialization preparations for NRL-1. Program has received Orphan Drug and Fast Track Designation from FDA. "We are very excited to ...

Acceptance of Investigational New Drug Application is another significant milestone in the effort to address the significant need for a therapy for acute repetitive seizures outside of the hospital ...

SAN DIEGO, June 8, 2020 /PRNewswire/ -- Neurelis, Inc., announced today that insurers and managed care plans now provide coverage for more than 176 million lives for the company's lead product, ...

Neurelis, Inc., a commercial-stage neuroscience company, announced the first two cohorts dosed in the investigational clinical trial of NRL-1049, a Rho kinase (ROCK) inhibitor, a potential treatment ...

SAN DIEGO, Aug. 19, 2022 /PRNewswire/ -- Neurelis and Little Angels Service Dogs are proud to present the "Barks 'n Blues Music & More" concert for epilepsy awareness at the Quartyard, 1301 Market St.

Opportunity to Develop Late-Stage Product for Treatment of Epileptic Seizures TURKU, FINLAND--(Marketwired - Jun 4, 2013) - Biotie Therapies Corp. ("Biotie") today announced that it has obtained an ...